Key facts
- This page summarizes Ajay Verma's Form 4 filing for YUMANITY THERAPEUTICS, INC. (KANT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Dec 2021, 15:15.
Ajay Verma - 01 Dec 2021 Form 4 Insider Report for YUMANITY THERAPEUTICS, INC. (KANT)
- Reporting relationship
- EVP, Head of R&D
- Issuer ticker
- KANT
- Reported as of
- 01 Dec 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Dec 2021, 15:15:58 UTC
- Prior SEC filing
- 15 Nov 2021
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marie Epstein, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Ajay Verma filed Form 4 for YUMANITY THERAPEUTICS, INC. (KANT) on 03 Dec 2021.
Change
- Previous filing in this sequence was filed on 15 Nov 2021.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +30,000
- Change %
- Price
- $0.000000
- Shares after
- 30,000
- Date
- 01 Dec 2021
- Ownership
- Direct
- Footnotes
- F1
KA
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 200
- Date
- 01 Dec 2021
- Ownership
- By Spouse
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Restricted stock award granted under the Yumanity Therapeutics, Inc. Amended and Restated 2018 Stock Option and Grant Plan. Fifty percent of the shares subject to the award will vest six months after the grant date and fifty percent will vest twelve months after the grant date, provided that the award recipient continues to have a service relationship with the Company at such time.